Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes

Table 2

Deep neovessels’ response to VEGF according to studies.

Series	Number of cases	Molecule	Follow-up period	Response
Vieira et al. 2012 [12]	6 cases	Bevacizumab	6 months	Total reduction: 4; Failure: 1
Yeung et al. 2011 [16]	12 cases	Bevacizumab	6 months	Complete reduction
Hashemian et al. 2011 [13]	1 case DALK	Bevacizumab	6 months	Complete reduction
Ahn et al. 2014 [23]	1 case	Ranibizumab	4 months	Partial reduction